A long-acting GLP-1 receptor agonist studied for incretin signaling and glucose-metabolism research.

| Compound | Semaglutide |
| Also known as | GLP-1 receptor agonist |
| CAS Number | 910463-68-2 |
| Molecular Weight | 4,113.58 g/mol |
| Sequence / Form | Synthetic GLP-1 analog |
| Classification | Metabolic research compound |
| Appearance | Lyophilized powder |
| Purity | ≥99% (HPLC · MS-verified) |
| Storage | 2–8°C; -20°C for long-term |
| Intended Use | Research Use Only |
Semaglutide is a long-acting synthetic analog of glucagon-like peptide-1, acting as an agonist of the GLP-1 receptor. Research models study its role in incretin signaling, glucose-dependent insulin secretion, and energy-homeostasis pathways.
As one of the most extensively studied GLP-1 receptor agonists, it serves as a common comparison standard in metabolic-pathway research.
Every Ethos Bio lot of Semaglutide is analyzed by reverse-phase HPLC and independently confirmed by mass spectrometry through our third-party testing partner, Janoshik Analytical. A signed Certificate of Analysis documenting identity and ≥99% purity is provided for every lot.
Independent third-party HPLC & mass-spec verification. The COA shipped with your order reflects your specific lot.
What is Semaglutide?
Semaglutide is a synthetic GLP-1 receptor agonist studied for incretin signaling and glucose metabolism in research models. It is a research-use-only compound.
What receptor does Semaglutide target?
Semaglutide is an agonist of the glucagon-like peptide-1 (GLP-1) receptor.
What is Semaglutide\u2019s molecular weight?
Semaglutide has a molecular weight of approximately 4,113.58 g/mol and CAS number 910463-68-2.